Users may also face additional expenses related to post-cycle therapy, hormone recovery, side-effect management, and treatment for potential cardiovascular, liver, or fertility complications
This substantial reduction in food noise with GLP1 RA drugs, when combined with behavioral treatment, is in line with previous anecdotal findings and may serve as an early indicator of treatment response. The team says this finding is important because food noise can make healthy behaviors much harder to maintain over time
Ongoing access to the patient care team and providers is described as available through the platform's app and portal at no additional cost, for questions about progress, side effects, or dosage throughout the program
For example, in real-world settings, semaglutide users reported an average weight loss of about 8% after one year, compared to nearly 15% seen in clinical trials